Atlas Trials

Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance

Clinical trial NCT04864405 · COMPLETED

Trial details

NCT number
NCT04864405
Sponsor
Ottawa Hospital Research Institute
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-06-30
Primary completion
2022-09-05
Enrollment
245

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.